Mustang Bio Inc (MBIO) stock is lower by -42.90% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. Stock Score Report, InvestorsObserver’s proprietary scoring system, gives MBIO stock a score of 57 out of a possible 100.
That score is primarily influenced by a fundamental score of 87. In addition to the average rating from Wall Street analysts, MBIO stock has a mean target price of $12.50. This means analysts expect the stock to gain 249.16% over the next 12 months. MBIO’s score also includes a short-term technical score of 54. The long-term technical score for MBIO is 29.
What’s Happening with MBIO Stock Today
Mustang Bio Inc (MBIO) stock is up 23.88% while the S&P 500 has gained 1.69% as of 2:48 PM on Tuesday, Aug 13. MBIO has gained $0.69 from the previous closing price of $2.89 on volume of 934,725 shares. Over the past year the S&P 500 has risen 3.91% while MBIO is lower by -42.90%. MBIO lost -$1.14 per share in the over the last 12 months.